アトラグループ resolved to enter into a capital and business alliance with REMED JAPAN. REMED JAPAN is expected to acquire 156,154 of the company's common shares for ¥78,077,000 and hold 35.0% of the voting rights. Payment is expected in early December 2026.
アトラグループ resolved to enter into a capital and business alliance with REMED JAPAN. REMED JAPAN will subscribe to a third-party allotment, acquire shares and raise its voting interest to 35%, with the company expected to become an equity-method affiliate.
The number of shares to be acquired is 156,154, at an acquisition price of ¥78,077,000. Payment is expected in early December 2026, and REMED JAPAN is expected to become an affiliate of the company after completion of the transaction.
Remed Japan is the exclusive distributor in Japan of all products manufactured by Remed Co., Ltd. The alliance aims to expand the provision of magnetic and shockwave medical equipment to approximately 3,000 clinics in the customer network of its management support platform for acupuncture and osteopathic clinics. The company has also positioned this as the first of its new business investments.
In the future, REMED JAPAN will be able to acquire a call option equivalent to 16% of Remed JAPAN's shares. If the option is exercised after the financial results for the fiscal year ending December 2028 are finalized, the voting interest will rise to 51%, and REMED JAPAN is expected to become a consolidated subsidiary.